Hi Megan,

 

I use the NYU Just Security litigation tracker for updates. It’s comprehensive and up to date. Screenshot of the AAU vs DOE case below.

 

https://www.justsecurity.org/107087/tracker-litigation-legal-challenges-trump-administration/

 

 

 

Erica A. Fletcher, EdM, CRA

Lead Research Administrator

Dana-Farber/Harvard Cancer Center

Dana-Farber Cancer Institute 
450 Brookline Avenue, BP2160 Boston, MA 02215

617-632-4864 phone 

(she/her/hers)

My work days are M-Th 9-5 (remote)

 

From: Roth, Megan - mroth8 at utk.edu (via resadm-l list) <xxxxxx@lists.healthresearch.org>
Sent: Wednesday, May 7, 2025 9:04 AM
To: xxxxxx@LISTS.HEALTHRESEARCH.ORG
Subject: [RESADM-L] DOE IDC Update?

 

        External Email - Use Caution        

Good Morning!

 

Has anyone seen any updates on the DOE IDC issue? I thought there was supposed to be a court date last week (4/28), but I could not find any follow up information related to that.

 

Thanks in advance!

 

Megan Roth, Ph.D., CRA
Interim Team Lead, Preaward Operations

The University of Tennessee, Knoxville
Division of Research Administration

Office of Research, Innovation & Economic Development

(865) 946-3153

xxxxxx@utk.edu

Call me on Teams

My standard working hours are 9:00 a.m. to 5:00 p.m. EST, M-F

 

Achiever | Relator | Competition | Strategic | Maximizer

 

 

- = - = - = - = - = - = -

This email was sent to xxxxxx@dfci.harvard.edu via the Research Administrator's mailing list.

To unsubscribe from RESADM-L, go to https://lists.healthresearch.org and enter your subscribed email address into the "My account and unsubscriptions" area at the bottom of the page. This also allows you to switch to Digest Mode or to temporarily suspend emails. You will be emailed a link to change all these settings.

List archives are available at: https://lists.healthresearch.org/resadm-l

Please keep in mind that responses are copied verbatim to 10,000+ users - - please refrain from "Me Too"s and clicking on reactions to emails. That will keep your email environment clean. Thanks!

The information transmitted in this electronic communication is intended only for the person or entity to whom it is addressed. It may also contain confidential and/or privileged material. Any use of the information transmitted by persons or entities other than the intended recipient is strictly prohibited. If this email was sent to you in error and includes sensitive Dana-Farber information (for example, patient information, Social Security Numbers, credit card information), please communicate this to Dana-Farber's Compliance Hotline at www.compliancereport.org . If the information transmitted does not contain such sensitive information, please contact the sender and properly dispose of the email.


Please note that this e-mail is not secure (encrypted).  If you do not wish to continue communication over unencrypted e-mail, please notify the sender of this message immediately.  Continuing to send or respond to e-mail after receiving this message means you understand and accept this risk and wish to continue to communicate over unencrypted e-mail.